Page last updated: 2024-08-24

zileuton and moclobemide

zileuton has been researched along with moclobemide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
de Andrés, L; Estrada Valencia, M; Herrera-Arozamena, C; Laurini, E; Morales-García, JA; Pérez, C; Pérez-Castillo, A; Pricl, S; Ramos, E; Rodríguez-Franco, MI; Romero, A; Viña, D; Yáñez, M1
Cuadrado, A; Duarte, P; Estrada-Valencia, M; Fernández-Ginés, R; Franco-Gonzalez, JF; Gago, F; García-Yagüe, ÁJ; Herrera-Arozamena, C; Lagartera, L; León, R; López, MG; Michalska, P; Mills, A; Morales-García, JA; Pérez, C; Pérez-Castillo, A; Rodríguez-Franco, MI1

Other Studies

3 other study(ies) available for zileuton and moclobemide

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease.
    European journal of medicinal chemistry, 2018, Aug-05, Volume: 156

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cell Line; Cholinesterase Inhibitors; Donepezil; Enzyme Inhibitors; Flavonoids; Humans; Indans; Lipoxygenase Inhibitors; Male; Mice, Inbred BALB C; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurogenesis; Neuroprotective Agents; Piperidines; Receptors, sigma; Sigma-1 Receptor

2018
Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties.
    European journal of medicinal chemistry, 2020, Mar-15, Volume: 190

    Topics: Animals; Antioxidants; Cell Line, Tumor; CHO Cells; Cricetulus; Humans; Indoles; Kelch-Like ECH-Associated Protein 1; Ligands; Lipoxygenase Inhibitors; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Monoamine Oxidase Inhibitors; Naphthalenes; Neurogenesis; NF-E2-Related Factor 2; Oxadiazoles; Protein Binding; Quinone Reductases; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2

2020